Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials-Reference-Cited by-同舟云学术

Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials

Published:2022-08 Issue: Volume:64 Page:136-142
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Pfaffendorf Charlotte,Vonthein Reinhard,Krockenberger-Ziegler Katja,Dellas Kathrin,Schreiber Andreas,Uhlemann Dorit,Dinges Stefan,Würschmidt Florian,Andreas Peter,Weinstrauch Evelyn,Eilf Kirsten,Rades Dirk,Höller Ulrike,Combs Stephanie E.,Kazmierczak Renata,Fehlauer Fabian,Schreck Ulrike,Zimmer Jörg,Dunst Jürgen,Krug David^ORCID

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference33 articles.

1. European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer;Meattini;Lancet Oncol,2022

2. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials;Haviland;Lancet Oncol,2013

3. Fraction size in radiation therapy for breast conservation in early breast cancer;Hickey;Cochrane Database Syst Rev,2016

4. Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial;Offersen;J Clin Oncol,2020

5. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial;Owen;Lancet Oncol,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients;Breast Cancer;2024-05-05

2. Methodological guide for assessing the carbon footprint of external beam radiotherapy: A single-center study with quantified mitigation strategies;Clinical and Translational Radiation Oncology;2024-05

3. Combined Ultrahypofractionated Whole-Breast Irradiation and IORT-Boost: A Safety and Feasibility Analysis;Cancers;2024-03-09

4. Single-Institution Prospective Evaluation of Moderately Hypofractionated Whole-Breast Radiation Therapy With Simultaneous Integrated Boost With or Without Lymphatic Drainage Irradiation After Breast-Conserving Surgery;Advances in Radiation Oncology;2023-11

5. Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III Trial;International Journal of Radiation Oncology*Biology*Physics;2023-11